Sterling Capital Management LLC Kal Vista Pharmaceuticals, Inc. Transaction History
Sterling Capital Management LLC
- $7.04 Trillion
- Q2 2025
A detailed history of Sterling Capital Management LLC transactions in Kal Vista Pharmaceuticals, Inc. stock. As of the latest transaction made, Sterling Capital Management LLC holds 91 shares of KALV stock, worth $1,079. This represents 0.0% of its overall portfolio holdings.
Number of Shares
91
Previous 41
121.95%
Holding current value
$1,079
Previous $473,000
117.55%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding KALV
# of Institutions
149Shares Held
54.3MCall Options Held
1.07MPut Options Held
90.1K-
Vr Adviser, LLC New York, NY6.73MShares$79.8 Million15.07% of portfolio
-
Suvretta Capital Management, LLC New York, NY4.96MShares$58.8 Million1.93% of portfolio
-
Tang Capital Management LLC San Diego, CA4.94MShares$58.6 Million3.35% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA4.89MShares$58 Million2.92% of portfolio
-
Vestal Point Capital, LP New York, NY4.68MShares$55.4 Million2.78% of portfolio
About KalVista Pharmaceuticals, Inc.
- Ticker KALV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,602,000
- Market Cap $292M
- Description
- KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...